<SEC-DOCUMENT>0001193125-18-343027.txt : 20181206
<SEC-HEADER>0001193125-18-343027.hdr.sgml : 20181206
<ACCEPTANCE-DATETIME>20181206082235
ACCESSION NUMBER:		0001193125-18-343027
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20181203
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20181206
DATE AS OF CHANGE:		20181206

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BAXTER INTERNATIONAL INC
		CENTRAL INDEX KEY:			0000010456
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				360781620
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-04448
		FILM NUMBER:		181218987

	BUSINESS ADDRESS:	
		STREET 1:		ONE BAXTER PKWY
		STREET 2:		DF2-1W
		CITY:			DEERFIELD
		STATE:			IL
		ZIP:			60015
		BUSINESS PHONE:		8479482000

	MAIL ADDRESS:	
		STREET 1:		ONE BAXTER PARKWAY
		STREET 2:		DF2-1W
		CITY:			DEERFIELD
		STATE:			IL
		ZIP:			60015

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BAXTER TRAVENOL LABORATORIES INC
		DATE OF NAME CHANGE:	19880522

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BAXTER LABORATORIES INC
		DATE OF NAME CHANGE:	19760608
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d657352d8k.htm
<DESCRIPTION>8-K
<TEXT>
<HTML><HEAD>
<TITLE>8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>UNITED STATES </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Washington, D.C. 20549
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>FORM <FONT STYLE="white-space:nowrap">8-K</FONT> </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>CURRENT REPORT </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>Pursuant to Section&nbsp;13 or 15(d) </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>of the Securities Exchange Act of
1934 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B></B>Date of Report (Date of earliest event reported):<B> <U>December&nbsp;3, 2018</U> </B></FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Baxter International Inc. </B></FONT></P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">(Exact name of registrant as
specified in its charter) </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Delaware </B></FONT></P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">(State or other jurisdiction of
incorporation) </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><FONT STYLE="white-space:nowrap">1-4448</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><FONT STYLE="white-space:nowrap">36-0781620</FONT></B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">(Commission File Number)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">(I.R.S. Employer Identification No.)</FONT></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>One Baxter Parkway, Deerfield, Illinois</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>60015</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">(Address of principal executive offices)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">(Zip Code)</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>(224) <FONT STYLE="white-space:nowrap">948-2000</FONT> </B></FONT></P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">(Registrant&#146;s telephone
number, including area code) </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></FONT></P> <P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">(Former name or
former address, if changed since last report) </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3">Check the appropriate box below if the Form <FONT STYLE="white-space:nowrap">8-K</FONT> filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#9744;&nbsp;&nbsp;&nbsp;&nbsp;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#9744;&nbsp;&nbsp;&nbsp;&nbsp;Soliciting material pursuant to Rule <FONT STYLE="white-space:nowrap">14a-12</FONT> under the Exchange Act
(17 CFR <FONT STYLE="white-space:nowrap">240.14a-12)</FONT> </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="3"><FONT STYLE="white-space:nowrap">&#9744;&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement</FONT> communications pursuant to Rule <FONT
STYLE="white-space:nowrap">14d-2(b)</FONT> under the Exchange Act (17 CFR 240.14d 2(b)) </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="3"><FONT STYLE="white-space:nowrap">&#9744;&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement</FONT> communications pursuant to Rule <FONT
STYLE="white-space:nowrap">13e-4(c)</FONT> under the Exchange Act (17 CFR 240.13e-4(c)) </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3">Indicate by check mark whether the registrant is an
emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <FONT STYLE="white-space:nowrap">12b-2</FONT> of the Securities Exchange Act of 1934
<FONT STYLE="white-space:nowrap">(&#167;240.12b-2</FONT> of this chapter): </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#9744;&nbsp;&nbsp;&nbsp;&nbsp;Emerging growth
company </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section&nbsp;13(a) of the Exchange Act:&nbsp;&nbsp;&nbsp;&nbsp;&#9744; </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Item&nbsp;5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain
Officers; Compensatory Arrangements of Certain Officers. </B></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><I>Election of Directors </I></FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3">On December&nbsp;3, 2018, Baxter International Inc. (the &#147;Company&#148;) appointed Mses. Patricia Morrison and Amy Wendell to the Company&#146;s
board of directors (the &#147;Board&#148;), each effective as of February&nbsp;18, 2019, the date of the next regularly scheduled meeting of the Board. Each of Ms.&nbsp;Morrison and Ms.&nbsp;Wendell was also appointed, effective as of
February&nbsp;18, 2019, to the Board&#146;s Audit Committee or Quality, Compliance&nbsp;&amp; Technology Committee, respectively. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3">Mses.
Morrison and Wendell will be compensated for service as a director pursuant to the Company&#146;s <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director Compensation Plan and will be eligible to participate in the Company&#146;s
Directors&#146; Deferred Compensation Plan. In connection with joining the Board, Mses. Morrison and Wendell will be granted equity awards as compensation for their 2019 service (representing the period between February&nbsp;18, 2019 and the
Company&#146;s 2019 Annual Meeting of Stockholders) in an amount consistent with the awards granted annually to <FONT STYLE="white-space:nowrap">non-employee</FONT> directors, prorated for the number of months to be served during such period in
accordance with the terms of the Company&#146;s <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director Compensation Plan. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3">In
connection with these appointments, the Company increased the size of the Company&#146;s Board by two directors to fourteen directors (effective as of February&nbsp;18, 2019) and appointed Mses. Morrison and Wendell to fill the newly created
vacancies. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Item&nbsp;8.01 Other Events. </B></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="3">On December&nbsp;6, 2018, the Company issued a press release announcing the appointment of Mses.&nbsp;Morrison and Wendell to the Board effective as of February&nbsp;18, 2019. A copy of this press release
is attached hereto as Exhibit 99.1 and is incorporated by reference herein. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Item&nbsp;9.01 Financial Statements and Exhibits.
</B></FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">(d)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">Exhibits. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="82%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000 ; display:table-cell;"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Exhibit</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Description of Document</B></FONT></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="3">99.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="3"><A HREF="d657352dex991.htm">Press Release of Baxter International Inc. dated December&nbsp;6, 2018 </A></FONT></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>SIGNATURES </B></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="3">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
</FONT></P> <P STYLE="margin-top:36px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3">Date: December&nbsp;6, 2018 </FONT></P> <P STYLE="font-size:36px;margin-top:0px;margin-bottom:0px">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="8%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="3">BAXTER INTERNATIONAL INC.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="3">By:</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="3">/<SMALL>S</SMALL>/ Ellen K. McIntosh</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">Ellen K. McIntosh</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">Senior Vice President and Corporate Secretary</FONT></TD></TR>
</TABLE></DIV>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d657352dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Exhibit 99.1 </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right">


<IMG SRC="g657352g66z29.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>FOR IMMEDIATE RELEASE </U></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Media Contact </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stacey Eisen, (224) <FONT STYLE="white-space:nowrap">948-5353</FONT>
</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">media@baxter.com </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Investor
Contact </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Clare Trachtman, (224) <FONT STYLE="white-space:nowrap">948-3085</FONT> </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>BAXTER APPOINTS PATRICIA MORRISON AND AMY WENDELL TO ITS BOARD </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Addition of industry veterans reflects ongoing board refreshment efforts and commitment to further diversification</I> </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Morrison&#146;s vast information technology expertise will advance Baxter&#146;s digital health strategies</I> </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Wendell&#146;s BD experience will enhance company&#146;s ongoing transformation and evaluation of inorganic growth opportunities</I>
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>DEERFIELD, Ill., DECEMBER&nbsp;6, 2018</B> &#151; Baxter International Inc. (NYSE:BAX), a leading global
medical products company, today announced it has appointed Patricia B. (Patty) Morrison, former Cardinal Health executive vice president and chief information officer, and Amy A. Wendell, former Covidien senior vice president of strategy and
business development, to its board of directors. These appointments will be effective Feb.&nbsp;18, 2019, in conjunction with the next regularly scheduled meeting of the board, and will bring the total number of directors serving the company to 14.
Ms.&nbsp;Morrison will serve on Baxter&#146;s Audit Committee and Ms.&nbsp;Wendell will serve on its Quality, Compliance and Technology Committee. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">&#147;We are pleased to welcome Patty and Amy to Baxter&#146;s board,&#148; said Jos&eacute; (Joe) E. Almeida, chairman and chief executive officer. &#147;Their deep corporate leadership experience and
differentiated expertise in their respective fields will enhance and further diversify our current board membership. I&#146;m confident their contributions will advance our goal to deliver sustainable
<FONT STYLE="white-space:nowrap">top-quartile</FONT> performance for our shareholders and support our mission to save and sustain lives.&#148; </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right">


<IMG SRC="g657352g66z29.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Patricia B. Morrison </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ms.&nbsp;Morrison most recently served as executive vice president, Customer Support Services and chief information officer (CIO), of
Cardinal Health, where she led global information technology (IT) operations, which included the transformation of multiple business segments, acquisition integration and digital strategy. Prior to Cardinal, Ms.&nbsp;Morrison served as CIO of both
Motorola and Office Depot, Inc., and held senior-level IT positions at General Electric Co., PepsiCo, Inc., The Procter&nbsp;&amp; Gamble Co. and The Quaker Oats Co. Ms.&nbsp;Morrison brings to Baxter more than a decade of public board service
across six industries and currently serves on the boards of<B> </B>Aramark and Splunk Inc.<B> </B>She received her bachelor&#146;s degrees in education, and mathematics and statistics, from Miami University. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Amy A. Wendell </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ms.&nbsp;Wendell is a senior advisor at Perella Weinberg Partners LP, consulting on strategy, corporate finance and investing practices in
the healthcare industry. She previously served as senior vice president of strategy and business development at Covidien plc, where she led the company&#146;s strategy and portfolio management initiatives and managed all business development
activities. Ms.&nbsp;Wendell held prior roles of increasing responsibility at Covidien (including its predecessors, Tyco Healthcare and Kendall Healthcare Products), from engineering to product management and business development. She currently
serves on the boards of Hologic, Inc. and Axogen, Inc. Ms.&nbsp;Wendell earned her bachelor&#146;s degree in mechanical engineering from Lawrence Technological University and her master&#146;s degree in biomedical engineering from the University of
Illinois. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>About Baxter </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Every day, millions of patients and caregivers rely on Baxter&#146;s leading portfolio of critical care, nutrition, renal, hospital and surgical products.&nbsp;For more than 85 years, we&#146;ve been
operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and&nbsp;therapies available in more than 100 countries, Baxter&#146;s employees
worldwide are now building upon the company&#146;s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit&nbsp;www.baxter.com&nbsp;and follow us
on&nbsp;Twitter,&nbsp;LinkedIn&nbsp;and&nbsp;Facebook. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Baxter is a registered trademark of Baxter International Inc. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">### </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g657352g66z29.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g657352g66z29.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #__@ ?3$5!1"!496-H;F]L;V=I97,@26YC
M+B!6,2XP,0#_VP!#  (! 0(! 0(" @(" @(" P4# P,# P8$! ,%!P8'!P<&
M!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_VP!# 0(" @,# P8#
M P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# S_P  1"  A )\# 2(  A$! Q$!_\0 'P   04! 0$! 0$
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M/B3JUK!K^M6<D5Q>7LD=O]O\NXFBBE/(^>6*..3 ]:]R_P"%Q^$?^AK\._\
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M  FGAW2XX/ /Q'EDN;=((OW6EZEC-S;^D?FY\V/_ +:_\\JXW_@D5_P4B/\
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MYWW[I;&^9<48A8"MC</3Y::5H2EO)O9J/;LV>L>%O^#EOQ9\3OB'H_AWP_\
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MK^ZKX)_X)I_!N3XZ_MZ?"CPW''))')XBM[^YV'_EWMO])D_\AQU^HG_$+?\
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)%% !1110!__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
